TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novo Nordisk A/S
Closing information (x1000 DKK)
| Closing information | 2019/12 | 2018/12 | 2017/12 (consolidated) |
| Turnover |
0
|
0
|
111,696,000 |
| Financial expenses | 1,533,000 | ||
| Earnings before taxes |
48,553,000
|
47,615,000
|
48,680,000 |
| Total assets |
125,612,000
|
110,769,000
|
102,355,000 |
| Current assets |
62,456,000
|
59,067,000
|
60,080,000 |
| Current liabilities |
58,983,000
|
54,164,000
|
47,056,000 |
| Equity capital |
57,593,000
|
51,839,000
|
49,815,000 |
| - share capital |
480,000
|
490,000
|
500,000 |
| Employees (average) |
1,000
|
1,000
|
42,682 |
Financial ratios
| Fiscal year | 2019/12 | 2018/12 | 2017/12 (consolidated) |
| Solvency |
45.8%
|
46.8%
|
48.7% |
| Turnover per employee |
0
|
0
|
2,617 |
| Profit as a percentage of turnover | 43.6% | ||
| Return on assets (ROA) | 49.1% | ||
| Current ratio |
105.9%
|
109.1%
|
127.7% |
| Return on equity (ROE) |
84.3%
|
91.9%
|
97.7% |
| Change turnover |
0
|
-111,696,000
|
-84,000 |
| Change turnover % | 0% | ||
| Chg. No. of employees |
0
|
-41,682
|
236 |
| Chg. No. of employees % | 0% | 1% |
Total value of public sale
| Fiscal year | 2019/12 | 2018/12 | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.